- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
12
Mid-Large Cap Stocks
12 companies
Novartis
Market Cap: CHF 175.0b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 90.34
7D
-0.8%
1Y
-2.5%
Tecan Group
Market Cap: CHF 2.2b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 173.50
7D
7.6%
1Y
-49.4%
Roche Holding
Market Cap: CHF 204.0b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 257.00
7D
-1.1%
1Y
9.5%
Bachem Holding
Market Cap: CHF 4.0b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 52.95
7D
5.8%
1Y
-42.1%
Cosmo Pharmaceuticals
Market Cap: CHF 840.8m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 52.20
7D
5.1%
1Y
-29.0%
Sandoz Group
Market Cap: CHF 16.4b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 38.40
7D
3.1%
1Y
19.0%
SKAN Group
Market Cap: CHF 1.6b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 70.30
7D
3.1%
1Y
-13.4%
Galderma Group
Market Cap: CHF 23.3b
Operates as a dermatology company worldwide.
GALD
CHF 97.80
7D
-0.6%
1Y
30.7%
Kuros Biosciences
Market Cap: CHF 924.7m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 23.56
7D
-1.0%
1Y
191.6%
Lonza Group
Market Cap: CHF 40.3b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 566.40
7D
-0.8%
1Y
7.4%
Dottikon ES Holding
Market Cap: CHF 2.8b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide.
DESN
CHF 205.50
7D
3.3%
1Y
-20.2%
Siegfried Holding
Market Cap: CHF 4.1b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 94.80
7D
-0.2%
1Y
7.0%